Industry: Medical Devices & Consumables
Published Date: 2025-01-18
Pages: 102 Pages
Report ld: 3434135
Request Sample
Customized Report
Biologic and Medical Imaging Reagents Market Size(US$)

CAGR 2025-2031
9.2%
Market Size,2031
USD 46,350
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Biologic and Medical Imaging Reagents was estimated to be worth US$ 25250 million in 2024 and is forecast to a readjusted size of US$ 46350 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.
The global well-known brands in Biologic and Medical Imaging Reagents include Cardinal Health(6.77%), Bracco(5.41%), Bayer HealthCare(3.48%), Curium Pharma(2.02%), Hengrui Medicine(2.67%), GE Healthcare(2.53%), Lantheus Medical Imaging(2.01%), Novartis (AAA)(2.77%), Thermo Fisher Scientific(2.16%), Jubilant DraxImage(1.63%), PerkinElmer(1.44%), Guerbet(1.75%), Nihon Medi-Physics(1.75%), YRPG(1.09%) and Others(62.52%).
The application area of Biologic and Medical Imaging Reagents include Hospitals, Clinics and Other.
In terms of types, Biologic and Medical Imaging Reagents can be divided into Nuclear Imaging (PET & SPECT) Reagents, Magnetic Resonance Imaging (MRI) Reagents, Fluorescence Imaging Reagents, Ultrasound and X-ray Contrast Reagents and Other.
On basis of geography, Biologic and Medical Imaging Reagents are manufactured in North America, Europe, China and Japan.
This report aims to provide a comprehensive presentation of the global market for Biologic and Medical Imaging Reagents, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biologic and Medical Imaging Reagents by region & country, by Type, and by Application.
The Biologic and Medical Imaging Reagents market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic and Medical Imaging Reagents.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Biologic and Medical Imaging Reagents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Biologic and Medical Imaging Reagents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Biologic and Medical Imaging Reagents in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Biologic and Medical Imaging Reagents Product Introduction
1.2 Global Biologic and Medical Imaging Reagents Market Size Forecast (2020-2031)
1.3 Biologic and Medical Imaging Reagents Market Trends & Drivers
1.3.1 Biologic and Medical Imaging Reagents Industry Trends
1.3.2 Biologic and Medical Imaging Reagents Market Drivers & Opportunity
1.3.3 Biologic and Medical Imaging Reagents Market Challenges
1.3.4 Biologic and Medical Imaging Reagents Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biologic and Medical Imaging Reagents Players Revenue Ranking (2024)
2.2 Global Biologic and Medical Imaging Reagents Revenue by Company (2020-2025)
2.3 Key Companies Biologic and Medical Imaging Reagents Manufacturing Base Distribution and Headquarters
2.4 Key Companies Biologic and Medical Imaging Reagents Product Offered
2.5 Key Companies Time to Begin Mass Production of Biologic and Medical Imaging Reagents
2.6 Biologic and Medical Imaging Reagents Market Competitive Analysis
2.6.1 Biologic and Medical Imaging Reagents Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Biologic and Medical Imaging Reagents Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic and Medical Imaging Reagents as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Nuclear Imaging (PET & SPECT) Reagents
3.1.2 Magnetic Resonance Imaging (MRI) Reagents
3.1.3 Fluorescence Imaging Reagents
3.1.4 Ultrasound and X-ray Contrast Reagents
3.1.5 Other
3.2 Global Biologic and Medical Imaging Reagents Sales Value by Type
3.2.1 Global Biologic and Medical Imaging Reagents Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Biologic and Medical Imaging Reagents Sales Value, by Type (2020-2031)
3.2.3 Global Biologic and Medical Imaging Reagents Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Other
4.2 Global Biologic and Medical Imaging Reagents Sales Value by Application
4.2.1 Global Biologic and Medical Imaging Reagents Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Biologic and Medical Imaging Reagents Sales Value, by Application (2020-2031)
4.2.3 Global Biologic and Medical Imaging Reagents Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Biologic and Medical Imaging Reagents Sales Value by Region
5.1.1 Global Biologic and Medical Imaging Reagents Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Biologic and Medical Imaging Reagents Sales Value by Region (2020-2025)
5.1.3 Global Biologic and Medical Imaging Reagents Sales Value by Region (2026-2031)
5.1.4 Global Biologic and Medical Imaging Reagents Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Biologic and Medical Imaging Reagents Sales Value, 2020-2031
5.2.2 North America Biologic and Medical Imaging Reagents Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Biologic and Medical Imaging Reagents Sales Value, 2020-2031
5.3.2 Europe Biologic and Medical Imaging Reagents Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Biologic and Medical Imaging Reagents Sales Value, 2020-2031
5.4.2 Asia Pacific Biologic and Medical Imaging Reagents Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Biologic and Medical Imaging Reagents Sales Value, 2020-2031
5.5.2 South America Biologic and Medical Imaging Reagents Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biologic and Medical Imaging Reagents Sales Value, 2020-2031
5.6.2 Middle East & Africa Biologic and Medical Imaging Reagents Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biologic and Medical Imaging Reagents Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Biologic and Medical Imaging Reagents Sales Value, 2020-2031
6.3 United States
6.3.1 United States Biologic and Medical Imaging Reagents Sales Value, 2020-2031
6.3.2 United States Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Biologic and Medical Imaging Reagents Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Biologic and Medical Imaging Reagents Sales Value, 2020-2031
6.4.2 Europe Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Biologic and Medical Imaging Reagents Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Biologic and Medical Imaging Reagents Sales Value, 2020-2031
6.5.2 China Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031
6.5.3 China Biologic and Medical Imaging Reagents Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Biologic and Medical Imaging Reagents Sales Value, 2020-2031
6.6.2 Japan Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Biologic and Medical Imaging Reagents Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Biologic and Medical Imaging Reagents Sales Value, 2020-2031
6.7.2 South Korea Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Biologic and Medical Imaging Reagents Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Biologic and Medical Imaging Reagents Sales Value, 2020-2031
6.8.2 Southeast Asia Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Biologic and Medical Imaging Reagents Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Biologic and Medical Imaging Reagents Sales Value, 2020-2031
6.9.2 India Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031
6.9.3 India Biologic and Medical Imaging Reagents Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Cardinal Health
7.1.1 Cardinal Health Profile
7.1.2 Cardinal Health Main Business
7.1.3 Cardinal Health Biologic and Medical Imaging Reagents Products, Services and Solutions
7.1.4 Cardinal Health Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)
7.1.5 Cardinal Health Recent Developments
7.2 Bracco
7.2.1 Bracco Profile
7.2.2 Bracco Main Business
7.2.3 Bracco Biologic and Medical Imaging Reagents Products, Services and Solutions
7.2.4 Bracco Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)
7.2.5 Bracco Recent Developments
7.3 Bayer HealthCare
7.3.1 Bayer HealthCare Profile
7.3.2 Bayer HealthCare Main Business
7.3.3 Bayer HealthCare Biologic and Medical Imaging Reagents Products, Services and Solutions
7.3.4 Bayer HealthCare Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)
7.3.5 Bayer HealthCare Recent Developments
7.4 Curium Pharma
7.4.1 Curium Pharma Profile
7.4.2 Curium Pharma Main Business
7.4.3 Curium Pharma Biologic and Medical Imaging Reagents Products, Services and Solutions
7.4.4 Curium Pharma Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)
7.4.5 Curium Pharma Recent Developments
7.5 Hengrui Medicine
7.5.1 Hengrui Medicine Profile
7.5.2 Hengrui Medicine Main Business
7.5.3 Hengrui Medicine Biologic and Medical Imaging Reagents Products, Services and Solutions
7.5.4 Hengrui Medicine Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)
7.5.5 Hengrui Medicine Recent Developments
7.6 GE Healthcare
7.6.1 GE Healthcare Profile
7.6.2 GE Healthcare Main Business
7.6.3 GE Healthcare Biologic and Medical Imaging Reagents Products, Services and Solutions
7.6.4 GE Healthcare Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)
7.6.5 GE Healthcare Recent Developments
7.7 Lantheus Medical Imaging
7.7.1 Lantheus Medical Imaging Profile
7.7.2 Lantheus Medical Imaging Main Business
7.7.3 Lantheus Medical Imaging Biologic and Medical Imaging Reagents Products, Services and Solutions
7.7.4 Lantheus Medical Imaging Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)
7.7.5 Lantheus Medical Imaging Recent Developments
7.8 Novartis (AAA)
7.8.1 Novartis (AAA) Profile
7.8.2 Novartis (AAA) Main Business
7.8.3 Novartis (AAA) Biologic and Medical Imaging Reagents Products, Services and Solutions
7.8.4 Novartis (AAA) Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)
7.8.5 Novartis (AAA) Recent Developments
7.9 Thermo Fisher Scientific
7.9.1 Thermo Fisher Scientific Profile
7.9.2 Thermo Fisher Scientific Main Business
7.9.3 Thermo Fisher Scientific Biologic and Medical Imaging Reagents Products, Services and Solutions
7.9.4 Thermo Fisher Scientific Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)
7.9.5 Thermo Fisher Scientific Recent Developments
7.10 Jubilant DraxImage
7.10.1 Jubilant DraxImage Profile
7.10.2 Jubilant DraxImage Main Business
7.10.3 Jubilant DraxImage Biologic and Medical Imaging Reagents Products, Services and Solutions
7.10.4 Jubilant DraxImage Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)
7.10.5 Jubilant DraxImage Recent Developments
7.11 PerkinElmer
7.11.1 PerkinElmer Profile
7.11.2 PerkinElmer Main Business
7.11.3 PerkinElmer Biologic and Medical Imaging Reagents Products, Services and Solutions
7.11.4 PerkinElmer Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)
7.11.5 PerkinElmer Recent Developments
7.12 Guerbet
7.12.1 Guerbet Profile
7.12.2 Guerbet Main Business
7.12.3 Guerbet Biologic and Medical Imaging Reagents Products, Services and Solutions
7.12.4 Guerbet Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)
7.12.5 Guerbet Recent Developments
7.13 Nihon Medi-Physics
7.13.1 Nihon Medi-Physics Profile
7.13.2 Nihon Medi-Physics Main Business
7.13.3 Nihon Medi-Physics Biologic and Medical Imaging Reagents Products, Services and Solutions
7.13.4 Nihon Medi-Physics Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)
7.13.5 Nihon Medi-Physics Recent Developments
7.14 YRPG
7.14.1 YRPG Profile
7.14.2 YRPG Main Business
7.14.3 YRPG Biologic and Medical Imaging Reagents Products, Services and Solutions
7.14.4 YRPG Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)
7.14.5 YRPG Recent Developments
8 Industry Chain Analysis
8.1 Biologic and Medical Imaging Reagents Industrial Chain
8.2 Biologic and Medical Imaging Reagents Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biologic and Medical Imaging Reagents Sales Model
8.5.2 Sales Channel
8.5.3 Biologic and Medical Imaging Reagents Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Biologic and Medical Imaging Reagents market size was US$ 27340 million in 2025 and is forecast to reach a readjusted size of US$ 50190 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 96
USD 4250.00
(Single User License)
The global Biologic and Medical Imaging Reagents market was valued at US$ 27340 million in 2025 and is anticipated to reach US$ 50190 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 119
USD 2900.00
(Single User License)
The global market for Biologic and Medical Imaging Reagents was estimated to be worth US$ 27340 million in 2025 and is projected to reach US$ 50190 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 119
USD 3950.00
(Single User License)
The global Biologic and Medical Imaging Reagents market size was US$ 25250 million in 2024 and is forecast to a readjusted size of US$ 46350 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 97
USD 4250.00
(Single User License)
The global Biologic and Medical Imaging Reagents market is projected to grow from US$ 25250 million in 2024 to US$ 46350 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-08
Pages: 144
USD 4900.00
(Single User License)
In 2024, the global market size of Biologic and Medical Imaging Reagents was estimated to be worth US$ 25250 million and is forecast to reach approximately US$ 46350 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 142
USD 5900.00
(Single User License)
The global market for Biologic and Medical Imaging Reagents was valued at US$ 25250 million in the year 2024 and is projected to reach a revised size of US$ 46350 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Published Date: 2025-01-18
Pages: 83
USD 2900.00
(Single User License)
Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.
Published Date: 2024-01-18
Pages: 115
USD 3950.00
(Single User License)
The global Biologic and Medical Imaging Reagents market size was US$ 27340 million in 2025 and is forecast to reach a readjusted size of US$ 50190 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 96
The global Biologic and Medical Imaging Reagents market was valued at US$ 27340 million in 2025 and is anticipated to reach US$ 50190 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 119
The global market for Biologic and Medical Imaging Reagents was estimated to be worth US$ 27340 million in 2025 and is projected to reach US$ 50190 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 119
The global Biologic and Medical Imaging Reagents market size was US$ 25250 million in 2024 and is forecast to a readjusted size of US$ 46350 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 97
The global Biologic and Medical Imaging Reagents market is projected to grow from US$ 25250 million in 2024 to US$ 46350 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-08
Pages: 144
In 2024, the global market size of Biologic and Medical Imaging Reagents was estimated to be worth US$ 25250 million and is forecast to reach approximately US$ 46350 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 142
The global market for Biologic and Medical Imaging Reagents was valued at US$ 25250 million in the year 2024 and is projected to reach a revised size of US$ 46350 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Published: 2025-01-18
Pages: 83
Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.
Published: 2024-01-18
Pages: 115
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now